Browse the world's most comprehensive database of hedge fund investor letters, sorted by recent quarter. Access primary source research from leading institutional managers.
| Quarter | Letter Date | Fund Name | QTD | YTD | Tickers | Themes | Quick Take |
|---|---|---|---|---|---|---|---|
Buyside Digest is not affiliated with, and does not endorse, Wasatch Small Cap Growth Strategy. This analysis is provided for institutional research purposes only and is not investment advice.
"The Wasatch Small Cap Growth Strategy suffered its worst underperformance in 25 years during 2025 by avoiding speculative, low-quality market-darling themes like biotech and AI. However, management remains constructive, expecting a major rebound as relative valuations reach decade-lows and strong portfolio fundamentals persist."
Wasatch Small Cap Growth Strategy experienced a challenging fourth quarter and calendar year 2025, underperforming its benchmark, the Russell 2000 Growth Index. The strategy ended the period with losses, marking its worst relative performance year in more than 25 years. The main drivers of underperformance were a lack of exposure to biotechnology stocks (which surged nearly 27% in Q4) and an active avoidance of speculative, non-earning thematic names (e.g., AI, crypto, quantum computing). Main detractors included Shift4 Payments (FOUR), Vital Farms (VITL), and Trex Co. (TREX). Key contributors included JFrog (FROG), Fabrinet (FN), and RBC Bearings (RBC). Despite the disappointing short-term results, management reports that portfolio fundamentals (ROA, ROE, and earnings growth) remain robust. Relative valuations are at their most attractive levels in a decade, leaving the team highly constructive on the strategy's return potential heading into 2026.
Sign in or create a free account to unlock full commentary, extracted equity pitches, and direct outbound manager source links with your 3 quarterly credits.
Algorithmic conviction, macroeconomic posture, and risk appetite signals extracted from this quarterly letter with qualitative explanations.
Market Conviction
High-conviction positioning: The Wasatch Small Cap Growth Strategy suffered its worst underperformance in 25 years during 2025 by avoiding speculative, low-quality market-darling themes like biotech and AI. Ho...
Growth Outlook
Market outlook remains above average conviction: The Wasatch Small Cap Growth Strategy suffered its worst underperformance in 25 years during 2025 by avoiding speculative, low-quality market-darling themes like biotech and AI. Ho...
Risk Appetite
Risk appetite posture is moderate conviction: The Wasatch Small Cap Growth Strategy suffered its worst underperformance in 25 years during 2025 by avoiding speculative, low-quality market-darling themes like biotech and AI. Ho...
Capital Deployment
Manager actively deployed capital into high-conviction opportunities. The Wasatch Small Cap Growth Strategy suffered its worst underperformance in 25 years during 2025 by avoiding speculative, low-quality market-darling themes like biotech and AI. Ho...
Forward Guidance
Forward guidance signal: The Wasatch Small Cap Growth Strategy suffered its worst underperformance in 25 years during 2025 by avoiding speculative, low-quality market-darling themes like biotech and AI. Ho...
Language Signal
Tone analysis indicates above average conviction language: The Wasatch Small Cap Growth Strategy suffered its worst underperformance in 25 years during 2025 by avoiding speculative, low-quality market-darling themes like biotech and AI. Ho...
Perceived Risk
Perceived risk level is evaluated as moderate conviction. The Wasatch Small Cap Growth Strategy suffered its worst underperformance in 25 years during 2025 by avoiding speculative, low-quality market-darling themes like biotech and AI. Ho...
Opportunity Density
Opportunity density index indicates high conviction actionable entry points. The Wasatch Small Cap Growth Strategy suffered its worst underperformance in 25 years during 2025 by avoiding speculative, low-quality market-darling themes like biotech and AI. Ho...
Time Horizon
Investment time horizon reflects a high conviction orientation. The Wasatch Small Cap Growth Strategy suffered its worst underperformance in 25 years during 2025 by avoiding speculative, low-quality market-darling themes like biotech and AI. Ho...
